|
WDR70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.27180513185021E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.63427082767021E-12 |
| Normal-vs-Stage2 |
4.49250000000845E-06 |
| Normal-vs-Stage3 |
3.04360000535908E-08 |
| Normal-vs-Stage4 |
1.17390541731766E-11 |
| Stage1-vs-Stage2 |
7.032800E-01 |
| Stage1-vs-Stage3 |
3.818000E-01 |
| Stage1-vs-Stage4 |
2.403000E-01 |
| Stage2-vs-Stage3 |
8.286800E-01 |
| Stage2-vs-Stage4 |
2.519600E-01 |
| Stage3-vs-Stage4 |
9.510200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76639813886936E-11 |
| Normal-vs-AfricanAmerican |
1.242080E-03 |
| Normal-vs-Asian |
2.90780000078428E-08 |
| Caucasian-vs-AfricanAmerican |
2.326400E-01 |
| Caucasian-vs-Asian |
9.864800E-01 |
| AfricanAmerican-vs-Asian |
2.874600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.98530130907693E-11 |
| Normal-vs-Female |
1.69599889687788E-11 |
| Male-vs-Female |
7.157200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05160324892495E-11 |
| Normal-vs-Age(41-60Yrs) |
2.05490069404846E-11 |
| Normal-vs-Age(61-80Yrs) |
7.0211003677656E-10 |
| Normal-vs-Age(81-100Yrs) |
1.840020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.579600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.008800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.174400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.075000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.010790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.390300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.396600E-04 |
| Classical-VS-Follicular |
1.71390000003324E-06 |
| Classical-VS-Other |
2.190400E-01 |
| Classical-VS-Normal |
6.69999999924897E-09 |
| Tall-VS-Follicular |
3.126600E-01 |
| Tall-VS-Other |
9.409200E-01 |
| Tall-VS-Normal |
1.68470015715627E-10 |
| Follicular-VS-Other |
6.268000E-01 |
| Follicular-VS-Normal |
1.63402624764331E-12 |
| Other-VS-Normal |
7.609300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21125331986605E-12 |
| Normal-vs-N1 |
6.98910040952683E-10 |
| N0-vs-N1 |
5.589200E-01 |
|
|
